---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-017006"
form_type: "8-K"
ticker: "SNWV"
cik: "0001417663"
company_name: "SANUWAVE Health, Inc."
filed_at: "2025-04-08T23:59:59+00:00"
generated_at: "2026-05-23T18:58:13.637374+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# SANUWAVE Health reports preliminary Q1 2025 revenue of $9.1M-$9.3M, up 57-61% YoY

## Summary
- Preliminary Q1 2025 revenue $9.1M-$9.3M, highest Q1 in company history; +57-61% vs Q1 2024.
- UltraMIST revenue up >65% YoY, constitutes ~99% of total revenues.
- Results slightly above upper end of guidance given in Q4 2024 earnings release (March 21, 2025).
- CEO Morgan Frank notes sales force restructuring complete; all manufacturing domestic, no significant tariff impact.
- Full Q1 2025 results expected around May 9, 2025.

## SEC filing metadata
- accession: 0001628280-25-017006
- form_type: 8-K
- ticker: SNWV
- cik: 0001417663
- company_name: SANUWAVE Health, Inc.
- filed_at: 2025-04-08T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1417663/000162828025017006/0001628280-25-017006-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1417663/000162828025017006/snwv-20250408.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-017006
- JSON: https://secwatch.observer/filing/0001628280-25-017006.json
- Plain text: https://secwatch.observer/filing/0001628280-25-017006.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.